AstraZeneca Earnings: Here’s Why the Stock is Falling Now

AstraZeneca PLC (NYSE:AZN) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 0.73%.

AstraZeneca PLC Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased 21.57% to $1.2 in the quarter versus EPS of $1.53 in the year-earlier quarter.

Revenue: Decreased 6.43% to $6.23 billion from the year-earlier quarter.

Actual vs. Wall St. Expectations: AstraZeneca PLC reported adjusted EPS income of $1.2 per share. By that measure, the company beat the mean analyst estimate of $1.16. It missed the average revenue estimate of $6.24 billion.

Key Stats (on next page)…

Revenue decreased 2.4% from $6.39 billion in the previous quarter. EPS decreased 14.89% from $1.41 in the previous quarter.

Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $1.39 to a profit $1.33. For the current year, the average estimate has moved up from a profit of $5.12 to a profit of $5.27 over the last ninety days.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]